- Investing Ideas
- /
- U.S. Healthcare Undervalued Stocks Based On Cash Flows
U.S. Healthcare Undervalued Stocks Based On Cash Flows
Results
7
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
7 companies
Definitive Healthcare
Market Cap: US$573.6m
Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.
DH
US$4.02
7D
-0.2%
1Y
-26.9%
Inspire Medical Systems
Market Cap: US$3.8b
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
INSP
US$130.26
7D
2.6%
1Y
-6.0%
Pennant Group
Market Cap: US$869.7m
Provides healthcare services in the United States.
PNTG
US$25.35
7D
-1.9%
1Y
-3.4%
STAAR Surgical
Market Cap: US$860.5m
Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
STAA
US$17.38
7D
4.6%
1Y
-61.6%
DexCom
Market Cap: US$32.7b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$85.33
7D
2.9%
1Y
-24.5%
Performant Healthcare
Market Cap: US$331.2m
Provides audit, recovery, and analytics services in the United States.
PHLT
US$4.23
7D
0.7%
1Y
50.0%
Alignment Healthcare
Market Cap: US$2.6b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$13.40
7D
2.0%
1Y
49.2%